Requested symbol wasn't found

U.S. Markets closed
Loading...
Loading...
  • American City Business Journals18 days ago

    Former Ariad CEO joins a familiar face on board of The Medicines Co., hinting at a sale

    The former CEO of Ariad Pharmaceuticals Inc., who spent the last year shaping up the Cambridge-based drug company for its $5.2 acquisition earlier this year, was just named to the board of a new biotech last week. There, as the newest board member of New Jersey-based The Medicines Company, Paris Panayiotopoulos joins a familiar face: Alex Denner, former chairman of Ariad (ARIA). The founder of hedge fund Sarissa Capital, an activist investor believed to have played a big role in orchestrating the sale of that company, was named to that same 11-member board just over a year ago.

  • Investopedia25 days ago

    Amgen's Blincyto sBLA Secures FDA Priority Review

    Amgen aims to expand the use of Blincyto for more indications of acute lymphoblastic leukemia

  • Market Realist2 months ago

    Who Is Incyte Collaborating With?

    Incyte’s (INCY) Jakafi is distributed in the United States through a network of specialty pharmacy providers and wholesalers for direct delivery.